Fabtech Technologies Ltd
Fabtech Technologies Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #5 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Fabtech Technologies Ltd Q4 FY26 key numbers
- Revenue
- There's a focus on increasing order pipeline, currently close to USD 200 million in hot leads.
As stated in Fabtech Technologies Ltd's Q4 FY26 earnings call transcript · published 15 Aug 2026. Reported figures, not investment advice.
The short version
The company targets sustained growth of 25-30% in top line/revenue. Fabtech Technologies projects approximately 25% growth in revenue going forward, reflecting sustained robust order pipelines and market expansion.
From Fabtech Technologies Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company targets sustained growth of 25-30% in top line/revenue.
- There's a focus on increasing order pipeline, currently close to USD 200 million in hot leads.
- Internal targets for order wins surpass publicly announced guidance.
- Strategic focus on bidding for pre-engineered buildings (PEB) and civil infrastructure to increase ticket sizes and control project timelines.
- Expansion in cost-effective markets like Africa to penetrate and grow market share.
- The current order pipeline is expected to deliver over the next 18 to 24 months.
- FY27 revenue targets were previously guided at INR 530 to 600 crores, reflecting consistent growth expectations.
- Margin protection and enhancement strategies are aligned with growth through larger, more integrated projects.
2 more points from Fabtech Technologies Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fabtech Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is actively deploying IPO funds with a focus on strategic investments, including the ongoing due diligence for a potential acquisition (JBN acquisition in the West).
- Capital deployment is cautious and targeted, ensuring proper evaluation before committing funds.
- A significant portion of IPO proceeds is earmarked for talent acquisition to strengthen internal capabilities.
2 more points from Fabtech Technologies Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fabtech Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current pipeline/order book is approximately ₹900 crores, expected to be delivered in the next 18 to 24 months.
- Internal targets for order bookings exceed publicly disclosed numbers.
- Hot lead pipeline valued around USD 200 million (approx. ₹1,600 crores), growing and being validated.
- Order conversion timelines depend heavily on client readiness and civil infrastructure; typically, greenfield projects take 24-27 months but recent efforts have reduced this by about 20%.
- Orders are geographically diversified across UAE, Saudi Arabia, Iraq, Kenya, North Africa (Algeria, Morocco, Egypt, Ethiopia).
- New orders have been booked in North and West Africa, Middle East, UAE from Q1 onwards.
2 more points from Fabtech Technologies Ltd's call on order book
Create a free account to keep reading this call
Fabtech Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹92 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fabtech Technologies Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Scie. (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic Ltd (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging and Path Lab Ltd (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fabtech Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fabtech Technologies Ltd Q4 FY26 results?
The company targets sustained growth of 25-30% in top line/revenue. Fabtech Technologies projects approximately 25% growth in revenue going forward, reflecting sustained robust order pipelines and market expansion.
What is Fabtech Technologies Ltd share price analysis?
Fabtech Technologies Ltd currently shows a neutral. The stock trades at a P/E of 13.8 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fabtech Technologies Ltd planning capital expenditure?
The company is actively deploying IPO funds with a focus on strategic investments, including the ongoing due diligence for a potential acquisition (JBN acquisition in the West).
Keep Fabtech Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.